Table 3.
MACE and In‐Hospital Outcome in STEMI Patients From the RENASICA II Study (N = 4555)
| Outcome | Relative Frequency (%) |
|---|---|
| MACE | |
| Case fatality rate | 10 |
| Recurrent ischemia | 12 |
| Reinfarction | 4 |
| Cardiogenic shock | 4 |
| Stroke | 1 |
| In‐hospital CV outcome | |
| Heart failure | 8 |
| Acute pulmonary edema | 5 |
| VT | 5 |
| Mitral regurgitation | 2 |
| Interventricular septal rupture | 0.3 |
| Pericarditis | 2 |
| Cardiac arrest | 6 |
| VF | 4 |
| Sustained VT | 1 |
| Other nonspecified | 1 |
| In‐hospital bleeding complications | |
| Major | 1 |
| Minor | 2 |
| Other | |
| Hypotension secondary to fibrinolytic therapy | 6 |
| Acute renal failure | 5 |
| Sepsis | 1 |
Abbreviations: CV, cardiovascular; MACE, major adverse cardiac events; RENASICA II, Registro Nacional de Síndromes Coronarios Agudos II; STEMI, ST‐elevation myocardial infarction; VF, ventricular fibrillation; VT, ventricular tachycardia.